Pentixafor

P024
Grade:
GMP product
Tested for sterility and bacterial endotoxins
Description:
Pentixafor is a peptide targeting the CXCR4 chemokine receptor. It can be labelled with ⁶⁸Ga for PET imaging of solid and hematologic malignancies.
⁶⁸Ga-pentixafor PET/CT provides a novel noninvasive tool to evaluate disease involvement in myeloproliferative neoplasms and other CXCR4-expressing cancers. It is also used in the research and development of radionuclide-drug conjugates (RDCs).
Molar weight:
1221.36 g/mol (net peptide)
Molecular formula:
C₆₀H₈₀N₁₄O₁₄ (net peptide)
CAS №:
1341207-62-2
Retest date:
Not less than 18 months from the manufacturing date
Packaging:
2R/4ml or 8R/10ml Type I glass vials with bromobutyl rubber stoppers
Storage conditions:
–20 ±5 °C
Transportation:
At 2–8 °C (less than 1 month)
Available quantities:
0.1 mg; 1.0 mg; custom quantity upon request
Quality parameters

Quality parameters

Appearance: White solid
Identification:
– HPLC: Retention time of main peak corresponds to the "Pentaxifor" reference standard
– Mass spectrometry: m/z = 1221.4 ± 4
Residual heavy metals (ICP-OES): ≤ 100 ppm
Purity (HPLC): ≥ 98.0%
Bacterial endotoxins (gel-clot method): ≤ 10.0 EU/vial
Sterility (direct inoculation method): Sterile (passes test)
Sterility tests are performed for sterile products, made in aseptic conditions (class A).
Other products